New Dual-Action therapy targets Hard-to-Treat prostate cancer
Disease control
Not yet recruiting
This study tests a new approach for men with a specific type of advanced prostate cancer that has stopped responding to standard treatments. It uses a special imaging agent to find cancer cells and then delivers targeted radiation to destroy them. The goal is to see if this combi…
Phase: PHASE1, PHASE2 • Sponsor: Chengdu StarRay Therapeutics Co., Ltd • Aim: Disease control
Last updated May 15, 2026 11:57 UTC